Drug Database
Back to search

Canada· CA-DIN-02402874

MYRBETRIQ

A drugs for urinary frequency and incontinence product containing mirabegron, registered in Canada by ASTELLAS PHARMA CANADA INC. The same ATC class is registered in 2 of our 19 countries.

ATC G04BD

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedMYRBETRIQATCG04BDREGISTER NO.CA-DIN-02402874PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mirabegronAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mirabegron is registered in 2 of 19 countries.

Countries holding a registration under ATC G04BD (drugs for urinary frequency and incontinence), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose
Search mirabegron products by name

Mirabegron · ATC G04BD

2 / 19 countries

  • Canada
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
MIRABEGRON
Manufacturer
ASTELLAS PHARMA CANADA INC
Country
Canada (CA)
ATC code
G04BD
ATC class
Drugs for urinary frequency and incontinence
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mirabegron in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mirabegron products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Mirabegron +pharma, Mirabegron G.L.
  • Belgium · Mirabegron Eg, Mirabegron Teva
  • Bulgaria · Иретиг, Мирабегрон G.L.
  • Cyprus · Macitentan, Mirabegron
  • Czechia · Begirax, Iretig
  • Germany · Mirabegron Al, Mirabegron Aristo
  • Denmark · Mirabegron Glenmark, Mirabegron Stada
  • Estonia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
  • Spain · Baxirto, Iretig
  • Finland · Mirabegron Avansor, Mirabegron Glenmark
  • France · Mirabegron Zentiva, Mirabegron Zentiva L.P.
  • United Kingdom (Northern Ireland) · Mirabegron Altair, Mirabegron Aspire
  • Greece · Iretig, Mirabegron Aristo Aristo
  • Croatia · Iretig, Mezyran
  • Hungary · Mirabegron Stada
  • Ireland · Mirabegron Ascend, Mirabegron Clonmel
  • Iceland · Betmiga, Iretig
  • Italy · Iretig, Mirabegron Doc
  • Liechtenstein · Betmiga
  • Lithuania · Mirabegron Zentiva, Mirabegron Zentiva K.S.
  • Luxembourg · Mirabegron Eg
  • Latvia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
  • Malta · Mirabegron, Mirabegron Clonmel
  • Netherlands · Mirabegron Cf, Mirabegron Glenmark
  • Norway · Betmiga, Mirabegron Glenmark
  • Poland · Begirax, Iretig
  • Portugal · Baxirto, Mirabegrom Alter
  • Romania · Iretig, Mirabegron G.L. Pharma
  • Sweden · Mirabegron Avansor, Mirabegron Glenmark
  • Slovenia · Gozi 25 Mg, Gozi 50 Mg
  • Slovakia · Mirabegron Glenmark, Mirabegron Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cea57985-d6bf-411b-b022-08d98780d6c5
GET /v1/drugs/cea57985-d6bf-411b-b022-08d98780d6c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02402874",
  "form": "TABLET (EXTENDED-RELEASE)",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G04BD",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "88770",
  "strengths": [
    "25 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "MIRABEGRON"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about mirabegron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console